Leptin and apigenin: antagonists in the apoptotic pathway of lung adenocarcinoma cell line

A. Bruno, M. Ferraro, E. Pace, P. Chanez, D. Di Majo, M. Giammanco, G. Bonsignore, V. Bellia, M. Gjomarkaj (Palermo, Italy; Montpellier, France)

Source: Annual Congress 2006 - Pathophysiology of lung disease
Session: Pathophysiology of lung disease
Session type: Thematic Poster Session
Number: 3873

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Bruno, M. Ferraro, E. Pace, P. Chanez, D. Di Majo, M. Giammanco, G. Bonsignore, V. Bellia, M. Gjomarkaj (Palermo, Italy; Montpellier, France). Leptin and apigenin: antagonists in the apoptotic pathway of lung adenocarcinoma cell line. Eur Respir J 2006; 28: Suppl. 50, 3873

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Counteracting effects of apigenin and leptin on lung adenocarcinoma cells
Source: Eur Respir J 2007; 30: Suppl. 51, 136s
Year: 2007

Magnolol can induce apoptosis in non-small cell lung cancer via caspase-independent pathway
Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Year: 2011

Blocking VEGF does not induce proapoptotic effects in the NSCLC cell line A549
Source: Annual Congress 2010 - New insights in the pathology of lung cancer
Year: 2010


P2X7 receptor regulates cell survival, inflammation processes and proliferation of lung carcinoma cells
Source: International Congress 2019 – Novel insights from in vitro and in vivo models of lung disease
Year: 2019

KPNB1-mediated PD-L1 nuclear translocation promotes non-small cell lung cancer cell proliferation via the Gas6/MerTK signalling pathway
Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Year: 2020

Toll-like receptor 3 is up-regulated and enhances anti-proliferative function in human non-small cell lung cancer
Source: Annual Congress 2008 - Lung cancer and other malignant diseases involving the lungs
Year: 2008

HIF-1α modulation by topoisomerase inhibitors in A549, a non-small cell lung cancer cell line
Source: Annual Congress 2007 - Biology in thoracic oncology
Year: 2007


Shikonin-induced necroptosis is enhanced by the inhibition of autophagy in non-small cell lung cancer cells
Source: International Congress 2016 – Basic science and case reports in lung cancer
Year: 2016

Differences in growth signaling pathway activation in small cell and non-small cell carcinomas of the lung
Source: Eur Respir J 2006; 28: Suppl. 50, 326s
Year: 2006

Ghrelin does not influence cancer progression in a lung cancer cell line and mice with lung adenocarcinoma
Source: International Congress 2018 – Lung cancer: from the bench to the bedside
Year: 2018

Salinomycin suppresses TGF-ß1-induced EMT by down-regulating MMP-2,9 via AMPK-SIRT1 pathway in a non-small cell lung cancer
Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells
Year: 2017

IRP2 as a potential modulator of cell proliferation, apoptosis and prognosis in nonsmall cell lung cancer
Source: Eur Respir J , 49 (4)  1600711; DOI: 10.1183/13993003.00711-2016
Year: 2017



LSC 2012 abstract – Effects of the Hedgehog (Hh) pathway inhibitor GDC-0449 on lung cancer cells and cisplatin resistant lung cancer cells are mediated by lung cancer stem cells (SPs)
Source: Annual Congress 2012 - New insights in the pathology of lung cancer
Year: 2012

Functional expressions of EGFP/LKB1 and its kinase domain induced apoptosis and enhanced chemosensitivity in lung cancer cell lines
Source: Eur Respir J 2004; 24: Suppl. 48, 5s
Year: 2004

Inhibition of autophagy potentiates pemetrexed and simvastatin-induced apoptotic cell death in malignant mesothelioma and non-small cell lung cancer cells
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015

Bile acid receptor mediates cancer-associated fibroblasts-induced migration and invasion of non-small cell lung cancer cells
Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells
Year: 2017

The death receptor Fas in CD3+T cells in patients with non-small cell lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 673s
Year: 2004

Involvement of Fas/FasL system in gemcitabine-induced lung cancer cell killing
Source: Annual Congress 2010 - Pathology of lung cancer
Year: 2010

Functional consequences of cathepsin L-deficiency in the human lung carcinoma cell line A549
Source: Eur Respir J 2001; 18: Suppl. 33, 75s
Year: 2001

Proteasome inhibitors modulate chemokine production in lung epithelial and monocytic cells
Source: Eur Respir J 2004; 24: 40-48
Year: 2004